SynthesisAging2021

No difference in hepatocellular carcinoma risk in chronic hepatitis B patients treated with tenofovir vs entecavir: evidence from an updated meta-analysis.

Jie Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.